Steven Park to Protein Kinase Inhibitors
This is a "connection" page, showing publications Steven Park has written about Protein Kinase Inhibitors.
Connection Strength
0.870
-
Au KM, Wang AZ, Park SI. Pretargeted delivery of PI3K/mTOR small-molecule inhibitor-loaded nanoparticles for treatment of non-Hodgkin's lymphoma. Sci Adv. 2020 Apr; 6(14):eaaz9798.
Score: 0.690
-
DiSogra KY, Tran T, Arnall JR, Janes A, Moore DC, Park SI. Ibrutinib treatment via alternative administration in a patient with chronic lymphocytic leukemia and dysphagia. J Oncol Pharm Pract. 2021 Jul; 27(5):1265-1269.
Score: 0.180